EMA to relocate to Amsterdam, the Netherlands
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
List view / Grid view
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
Researchers have identified three specific molecules that accurately indicate insulin resistance - a major predictor of diabetes...
Researchers have described a unique model for the biology of Alzheimer's disease which may lead to an entirely novel approach for treating the disease...
A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...
Scientists have made a discovery that could reduce the spread of cancer by hindering a protein that binds cancer cells together and allows them to invade tissues...
Researchers have identified a possible genetic basis for coronary artery disease...
Researchers have identified a protein that can be targeted to suppress the growth of a common type of breast cancer...
Wayne Pines, President of Healthcare at APCO Worldwide in Washington DC and a former Associate Commissioner of the FDA believes Milan is a logical choice for the relocation of the EMA...
Researchers have developed a potential alternative to gadolinium-based contrast agents for magnetic resonance imaging...
Researchers have successfully reversed type 1 diabetes by infusing blood stem cells pre-treated to produce more PD-L1...
A study has identified a molecular pathway that appears to be critical to the development of fibrosis...
Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease...
Researchers have compiled an atlas of the heart to identify differences between healthy and diseased cells...
A British biopharmaceuticals company, have developed Antibiotic Resistance Breakers which can restore the original potency against both Gram-positive and Gram-negative bacteria...
A synthetic double-stranded RNA has potential for use as an anti-liver cancer vaccine...